Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
Chain B, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
Chain A, ADP-dependent glucokinase | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, phosphodiesterase-nucleotide pyrophosphatase | 0 | 1 | 0 | 1 |
Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
Chain B, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
AR protein | 7 | 0 | 0 | 7 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 6 | 0 | 0 | 6 |
estrogen-related nuclear receptor alpha | 6 | 0 | 0 | 6 |
euchromatic histone-lysine N-methyltransferase 2 | 6 | 0 | 0 | 6 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
Alcohol dehydrogenase E chain | 0 | 1 | 0 | 1 |
Alcohol dehydrogenase S chain | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 1 | 2 |
Adenylate kinase isoenzyme 1 | 0 | 0 | 0 | 1 |
Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 0 | 0 | 1 |
Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
5'-nucleotidase | 0 | 0 | 0 | 1 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 2 |
GTP:AMP phosphotransferase AK3, mitochondrial | 0 | 0 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 2 | 5 |
Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 2 |
P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 2 | 2 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 1 | 1 |
Adenylate kinase 2, mitochondrial | 0 | 0 | 0 | 1 |
Glycine--tRNA ligase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 2 | 2 |
Adenosine deaminase-like protein | 0 | 0 | 0 | 1 |
Protease | 0 | 1 | 1 | 2 |
P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 1 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 1 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 2 | 2 |
ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
TDP1 protein | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
estrogen nuclear receptor alpha | 7 | 0 | 0 | 7 |
peroxisome proliferator activated receptor gamma | 5 | 0 | 0 | 5 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 6 | 0 | 0 | 6 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 2 | 0 | 4 |
Bromodomain-containing protein 4 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 2 | 0 | 4 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 2 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 2 | 0 | 4 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
GABA theta subunit | 2 | 2 | 0 | 4 |
ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
Ataxin-2 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 2 | 0 | 4 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
Caspase-7 | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
caspase-3 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 5 | 0 | 0 | 5 |
geminin | 6 | 0 | 0 | 6 |
Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
Cellular tumor antigen p53 | 5 | 0 | 0 | 5 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Insulin receptor | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 4 | 0 | 0 | 4 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 3 | 0 | 3 |
Histone deacetylase 2 | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 2 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
GLS protein | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 5 | 0 | 5 |
Multidrug resistance-associated protein 4 | 0 | 5 | 0 | 5 |
Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
Bile salt export pump | 0 | 8 | 0 | 8 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 7 | 0 | 7 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 7 | 3 | 11 |
Adenosine receptor A1 | 0 | 2 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 1 | 4 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A2b | 0 | 2 | 0 | 3 |
Adenosine receptor A2a | 0 | 2 | 0 | 4 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 2 | 2 | 4 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 5 | 0 | 5 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
PINK1 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
progesterone receptor | 2 | 0 | 0 | 2 |
Parkin | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
Histone H2A.x | 1 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
prostaglandin E2 receptor EP2 subtype | 0 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
ORF73 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
Acetylcholinesterase | 0 | 5 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 2 | 0 | 2 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Liver carboxylesterase 1 | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 5 | 0 | 5 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 5 | 1 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Acetylcholine receptor subunit epsilon | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 2 | 0 | 2 |
Carboxylic ester hydrolase | 0 | 6 | 0 | 6 |
Histamine H3 receptor | 0 | 2 | 0 | 2 |
Chain A, ACETYLCHOLINESTERASE | 0 | 1 | 0 | 1 |
Chain A, Acetylcholinesterase | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
thioredoxin reductase | 2 | 0 | 0 | 2 |
GALC protein | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 2 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
Synaptic vesicle glycoprotein 2A | 0 | 1 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
ClpP | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit epsilon | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase SYK | 0 | 1 | 0 | 1 |
Sphingosine kinase 2 | 0 | 2 | 0 | 2 |
Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
Plasminogen | 0 | 2 | 1 | 3 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
Luciferase | 1 | 0 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |